Cargando…
Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests
Three types of immunochromatographic assays (ICAs) were designed to detect anti-feline coronavirus (FCoV) antibodies. Recombinant FCoV nucleocapsid protein (rNP) was used as a conjugate or test line in all 3 ICA kits ((CJ)IgG/(T)NP, (CJ)NP/(T)NP, and (CJ)NP/(T)PA). All three ICA kits were capable of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113643/ https://www.ncbi.nlm.nih.gov/pubmed/24516876 http://dx.doi.org/10.1016/j.jviromet.2013.10.014 |
_version_ | 1783513716409499648 |
---|---|
author | Takano, Tomomi Ishihara, Yuka Matsuoka, Masafumi Yokota, Shoko Matsuoka-Kobayashi, Yukie Doki, Tomoyoshi Hohdatsu, Tsutomu |
author_facet | Takano, Tomomi Ishihara, Yuka Matsuoka, Masafumi Yokota, Shoko Matsuoka-Kobayashi, Yukie Doki, Tomoyoshi Hohdatsu, Tsutomu |
author_sort | Takano, Tomomi |
collection | PubMed |
description | Three types of immunochromatographic assays (ICAs) were designed to detect anti-feline coronavirus (FCoV) antibodies. Recombinant FCoV nucleocapsid protein (rNP) was used as a conjugate or test line in all 3 ICA kits ((CJ)IgG/(T)NP, (CJ)NP/(T)NP, and (CJ)NP/(T)PA). All three ICA kits were capable of detecting anti-FCoV antibodies; however, non-specific positive reactions of anti-FCoV antibody-negative plasma samples with the test line were observed in 2 ICA kits ((CJ)IgG/(T)NP and (CJ)NP/(T)NP), in which rNP was used as the test line. On the other hand, the specific detection of anti-FCoV antibodies was possible in all plasma, serum, whole blood, and ascitic fluid samples using the ICA kit with protein A blotted as the test line ((CJ)NP/(T)PA). In addition, the specificity and sensitivity of ICA ((CJ)NP/(T)PA) were equivalent to those of the reference ELISA. The development of simple antibody test methods using the principle of ICA ((CJ)NP/(T)PA) for other coronavirus and feline viral infections is expected in the future. |
format | Online Article Text |
id | pubmed-7113643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71136432020-04-02 Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests Takano, Tomomi Ishihara, Yuka Matsuoka, Masafumi Yokota, Shoko Matsuoka-Kobayashi, Yukie Doki, Tomoyoshi Hohdatsu, Tsutomu J Virol Methods Article Three types of immunochromatographic assays (ICAs) were designed to detect anti-feline coronavirus (FCoV) antibodies. Recombinant FCoV nucleocapsid protein (rNP) was used as a conjugate or test line in all 3 ICA kits ((CJ)IgG/(T)NP, (CJ)NP/(T)NP, and (CJ)NP/(T)PA). All three ICA kits were capable of detecting anti-FCoV antibodies; however, non-specific positive reactions of anti-FCoV antibody-negative plasma samples with the test line were observed in 2 ICA kits ((CJ)IgG/(T)NP and (CJ)NP/(T)NP), in which rNP was used as the test line. On the other hand, the specific detection of anti-FCoV antibodies was possible in all plasma, serum, whole blood, and ascitic fluid samples using the ICA kit with protein A blotted as the test line ((CJ)NP/(T)PA). In addition, the specificity and sensitivity of ICA ((CJ)NP/(T)PA) were equivalent to those of the reference ELISA. The development of simple antibody test methods using the principle of ICA ((CJ)NP/(T)PA) for other coronavirus and feline viral infections is expected in the future. Elsevier B.V. 2014-02 2013-10-26 /pmc/articles/PMC7113643/ /pubmed/24516876 http://dx.doi.org/10.1016/j.jviromet.2013.10.014 Text en Copyright © 2013 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Takano, Tomomi Ishihara, Yuka Matsuoka, Masafumi Yokota, Shoko Matsuoka-Kobayashi, Yukie Doki, Tomoyoshi Hohdatsu, Tsutomu Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests |
title | Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests |
title_full | Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests |
title_fullStr | Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests |
title_full_unstemmed | Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests |
title_short | Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests |
title_sort | use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113643/ https://www.ncbi.nlm.nih.gov/pubmed/24516876 http://dx.doi.org/10.1016/j.jviromet.2013.10.014 |
work_keys_str_mv | AT takanotomomi useofrecombinantnucleocapsidproteinsforserologicaldiagnosisoffelinecoronavirusinfectionbythreeimmunochromatographictests AT ishiharayuka useofrecombinantnucleocapsidproteinsforserologicaldiagnosisoffelinecoronavirusinfectionbythreeimmunochromatographictests AT matsuokamasafumi useofrecombinantnucleocapsidproteinsforserologicaldiagnosisoffelinecoronavirusinfectionbythreeimmunochromatographictests AT yokotashoko useofrecombinantnucleocapsidproteinsforserologicaldiagnosisoffelinecoronavirusinfectionbythreeimmunochromatographictests AT matsuokakobayashiyukie useofrecombinantnucleocapsidproteinsforserologicaldiagnosisoffelinecoronavirusinfectionbythreeimmunochromatographictests AT dokitomoyoshi useofrecombinantnucleocapsidproteinsforserologicaldiagnosisoffelinecoronavirusinfectionbythreeimmunochromatographictests AT hohdatsutsutomu useofrecombinantnucleocapsidproteinsforserologicaldiagnosisoffelinecoronavirusinfectionbythreeimmunochromatographictests |